Goldman Sachs’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $101K | Buy |
95,073
+4,810
| +5% | +$5.1K | ﹤0.01% | 4879 |
|
|
2025
Q1 | $98.4K | Sell |
90,263
-30,982
| -26% | -$33.8K | ﹤0.01% | 4823 |
|
|
2024
Q4 | $183K | Sell |
121,245
-388,759
| -76% | -$587K | ﹤0.01% | 4685 |
|
|
2024
Q3 | $760K | Sell |
510,004
-298,740
| -37% | -$445K | ﹤0.01% | 3909 |
|
|
2024
Q2 | $1.31M | Sell |
808,744
-286,506
| -26% | -$464K | ﹤0.01% | 3460 |
|
|
2024
Q1 | $1.86M | Buy |
1,095,250
+292,375
| +36% | +$497K | ﹤0.01% | 3247 |
|
|
2023
Q4 | $2.49M | Sell |
802,875
-140,616
| -15% | -$436K | ﹤0.01% | 3074 |
|
|
2023
Q3 | $5.79M | Buy |
943,491
+304,446
| +48% | +$1.87M | ﹤0.01% | 2358 |
|
|
2023
Q2 | $4M | Sell |
639,045
-14,586
| -2% | -$91.3K | ﹤0.01% | 2722 |
|
|
2023
Q1 | $3.12M | Buy |
653,631
+45,681
| +8% | +$218K | ﹤0.01% | 2899 |
|
|
2022
Q4 | $5.29M | Buy |
607,950
+81,486
| +15% | +$709K | ﹤0.01% | 2579 |
|
|
2022
Q3 | $6.27M | Buy |
526,464
+49,530
| +10% | +$589K | ﹤0.01% | 2480 |
|
|
2022
Q2 | $6.8M | Buy |
476,934
+58,889
| +14% | +$839K | ﹤0.01% | 2422 |
|
|
2022
Q1 | $8.7M | Buy |
418,045
+168,803
| +68% | +$3.51M | ﹤0.01% | 2350 |
|
|
2021
Q4 | $5.76M | Sell |
249,242
-44,598
| -15% | -$1.03M | ﹤0.01% | 2692 |
|
|
2021
Q3 | $8.76M | Buy |
293,840
+138,463
| +89% | +$4.13M | ﹤0.01% | 2370 |
|
|
2021
Q2 | $5.31M | Buy |
155,377
+74,516
| +92% | +$2.55M | ﹤0.01% | 2744 |
|
|
2021
Q1 | $2.66M | Buy |
+80,861
| New | +$2.66M | ﹤0.01% | 3140 |
|
|
2020
Q4 | – | Sell |
-167,751
| Closed | -$5.96M | – | 4726 |
|
|
2020
Q3 | $5.96M | Buy |
+167,751
| New | +$5.96M | ﹤0.01% | 2275 |
|